Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $9,372 - $10,762
362 Added 5.15%
7,386 $204,000
Q4 2023

Jan 30, 2024

SELL
$26.13 - $33.94 $34,387 - $44,665
-1,316 Reduced 15.78%
7,024 $202,000
Q3 2023

Oct 19, 2023

SELL
$32.09 - $37.51 $58,917 - $68,868
-1,836 Reduced 18.04%
8,340 $276,000
Q2 2023

Aug 04, 2023

SELL
$36.12 - $41.79 $13,147 - $15,211
-364 Reduced 3.45%
10,176 $373,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $21,979 - $28,614
558 Added 5.59%
10,540 $430,000
Q4 2022

Jan 26, 2023

SELL
$41.75 - $54.5 $40,038 - $52,265
-959 Reduced 8.77%
9,982 $0
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $3,675 - $4,487
84 Added 0.77%
10,941 $479,000
Q2 2022

Jul 20, 2022

SELL
$46.53 - $55.17 $19,356 - $22,950
-416 Reduced 3.69%
10,857 $569,000
Q1 2022

Apr 21, 2022

BUY
$45.75 - $56.69 $21,777 - $26,984
476 Added 4.41%
11,273 $584,000
Q4 2021

Feb 04, 2022

BUY
$41.32 - $61.25 $16,238 - $24,071
393 Added 3.78%
10,797 $638,000
Q3 2021

Nov 01, 2021

BUY
$39.25 - $50.42 $6,476 - $8,319
165 Added 1.61%
10,404 $447,000
Q2 2021

Jul 20, 2021

BUY
$35.91 - $40.68 $28,297 - $32,055
788 Added 8.34%
10,239 $401,000
Q1 2021

Apr 26, 2021

BUY
$33.49 - $37.77 $21,199 - $23,908
633 Added 7.18%
9,451 $342,000
Q2 2020

Jul 29, 2020

SELL
$30.12 - $36.54 $7,891 - $9,573
-262 Reduced 2.89%
8,818 $288,000
Q1 2020

Apr 16, 2020

SELL
$27.03 - $38.62 $11,055 - $15,795
-409 Reduced 4.31%
9,080 $296,000
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $312,377 - $354,509
9,489 New
9,489 $372,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ballast Advisors LLC Portfolio

Follow Ballast Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballast Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballast Advisors LLC with notifications on news.